THE MEDICINES COMPANY
The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex(R) (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has two products in late stage development: cangrelor, an investigational antiplatelet agent, and oritavancin, a semi-synthetic lipoglycopeptide antibiotic. The Company's pipeline also includes a serine protease inhibitor, CU2010, in early-stage development.
THE MEDICINES COMPANY
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1996-01-01
Address:
Parsippany, New Jersey, United States
Country:
United States
Website Url:
http://www.themedicinescompany.com
Total Employee:
1001+
Status:
Closed
Contact:
(973) 290-6000
Total Funding:
0
Technology used in webpage:
Global Site Tag IPv6 CDN JS Cloudflare Hosting IIS IIS 7 Cookie Consent By Osano Silktide Cookie Consent ASP.NET 2.0 Akamai DNS
Current Advisors List
Board_member
Board_member
Current Employees Featured
Mark Timney CEO & Member of the Board @ The Medicines Company
CEO & Member of the Board
2018-12-01
Elizabeth Morgan VP. Clinical and RA/QA Operations @ The Medicines Company
VP. Clinical and RA/QA Operations
2012-12-01
Rob Rode Independent Consultant @ The Medicines Company
Independent Consultant
2020-01-01
Jeff Frazier Executive Vice President @ The Medicines Company
Executive Vice President
Bruce Rosengard Vice President, New Business Ventures @ The Medicines Company
Vice President, New Business Ventures
2012-07-01
Stephanie Plent Executive Vice President @ The Medicines Company
Executive Vice President
Nancye Green Executive Vice President @ The Medicines Company
Executive Vice President
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-02-04 | Annovation BioPharma | Annovation BioPharma acquired by The Medicines Company | N/A |
| 2014-04-23 | Tenaxis Medical | Tenaxis Medical acquired by The Medicines Company | N/A |
| 2013-12-04 | Rempex Pharmaceuticals | Rempex Pharmaceuticals acquired by The Medicines Company | 474 M USD |
| 2013-08-05 | ProFibrix | ProFibrix acquired by The Medicines Company | 240 M USD |
| 2012-12-12 | Incline Therapeutics | Incline Therapeutics acquired by The Medicines Company | N/A |
| 2009-12-22 | ApoA-I Milano | ApoA-I Milano acquired by The Medicines Company | N/A |
| 2009-01-13 | Targanta Therapeutics | Targanta Therapeutics acquired by The Medicines Company | 42 M USD |
| 2008-08-05 | Curacyte Discovery GmbH | Curacyte Discovery GmbH acquired by The Medicines Company | N/A |
Investors List
Hanseatic Asset Management
Hanseatic Asset Management investment in Venture Round - The Medicines Company
Biotech Growth
Biotech Growth investment in Venture Round - The Medicines Company
Credit Suisse
Credit Suisse investment in Venture Round - The Medicines Company
Warburg Pincus
Warburg Pincus investment in Venture Round - The Medicines Company
Alta Partners
Alta Partners investment in Venture Round - The Medicines Company
GeneChem
GeneChem investment in Venture Round - The Medicines Company
Moore Capital
Moore Capital investment in Venture Round - The Medicines Company
BancAmerica Robertson Stephens
BancAmerica Robertson Stephens investment in Venture Round - The Medicines Company
Morgan Stanley Venture Partners
Morgan Stanley Venture Partners investment in Venture Round - The Medicines Company
Official Site Inspections
http://www.themedicinescompany.com
- Host name: 104.18.2.191
- IP address: 104.18.2.191
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "The Medicines Company"
The Medicines Company - Crunchbase Company Profile & Funding
The Medicines Company is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The …See details»
Company Profile for The Medicines Company | Business Wire
Nov 9, 2018 The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the econom ... Type of …See details»
Our Company | The Medicines Company - Targanta
Jan 3, 2018 The Medicines Company Announces Closing of Divestiture of Infectious Disease Business Unit to Melinta Therapeutics. 3 Jan 2018. The Medicines Company to Present at the …See details»
The Medicines Company Company Profile | Parsippany, NJ
Find company research, competitor information, contact details & financial data for The Medicines Company of Parsippany, NJ. Get the latest business insights from Dun & Bradstreet. The …See details»
Organization | The Medicines Company - Purdue University
Organization Overview. First Clinical Trial. 1999 NCT00043940. First Marketed Drug. 2000 ... THE MEDICINES CO | The Medicines Company | The Medicines Company - Medical Director, …See details»
Leadership Team | The Medicines Company - targanta.com
Nancye Green leads global communications & information architecture for The Medicines Company (MDCO). A designer and business leader, Nancye has had a storied career …See details»
Board of Directors | The Medicines Company
He is a graduate of the OPM program at Harvard Business School. Robert J. Hugin. Independent Director, Member of Compensation Committee. Robert J. Hugin has been a director since April 2003. Mr. ... Corporate Secretary The Medicines Company 8 Sylvan Way Parsippany, NJ 07054 United States. Communications are distributed to the Board, or to any ...See details»
Company Profile for The Medicines Company - BioSpace
Nov 9, 2018 The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. ...See details»
Company The Medicines Company - MarketScreener.com
Business description: The Medicines Company The Medicines Company is a global biopharmaceutical company. The Company is focused on the development of inclisiran, a …See details»
THE MEDICINES COMPANY (SAN DIEGO), LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for THE MEDICINES COMPANY (SAN DIEGO), LLC of San Diego, CA. ... Get the latest business …See details»
The Medicines Company Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for The Medicines Company of Parsippany, NJ. Get the latest business insights from Dun & Bradstreet. The …See details»
The Medicines Company - Craft
Jan 6, 2020 The Medicines Company. Financials. Summary Financials. Net income (Q3, 2019)($74.0M) Cash (Q3, 2019)$265.9M EBIT (Q3, 2019)($61.4M) Enterprise value $6.9B. …See details»
Company Profile for The Medicines Company - BioSpace
Nov 9, 2018 --(BUSINESS WIRE)-- The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the …See details»
The Medicines Company: Shareholders Board Members …
The Medicines Company: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Deutsche Boerse AG ...See details»
Governance The Medicines Company - MarketScreener.com
The Medicines Company is a global biopharmaceutical company. The Company is focused on the development of inclisiran, a twice-yearly therapy that allows administration during patients …See details»
The Medicines Company - Funding, Financials, Valuation & Investors
The Medicines Company is registered under the ticker NASDAQ:MDCO . Their stock opened with $16.00 in its Aug 18, 2000 IPO. The Medicines Company is funded by 9 investors. Hanseatic …See details»
The Medicines Company - PitchBook
Jan 22, 2016 The Medicines Company General Information Description. The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The …See details»
Company Profile for The Medicines Company - MarketScreener
Nov 9, 2018 The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The …See details»
Novartis to acquire The Medicines Company for USD 9.7 bn, …
Nov 24, 2019 The offer price represents a premium of approximately 41% over The Medicines Company’s 30-day (to November 22, 2019) volume weighted average price of USD 60.33 and …See details»
The Medicines Company Management Team | Org Chart
The Medicines Company employs 329 employees. The The Medicines Company management team includes Bruce Rosengard (Vice President, New Business Ventures), Stephanie Plent (Executive Vice President, Chief Value Officer), and Bill O'Connor (EVP, Chief Financial Officer). Get Contact Info for All DepartmentsSee details»